FDA clears Amgen’s Prolia for glucocorticoid osteoporosis
admin 23rd May 2018 Uncategorised 0US regulators have approved a new indication for Amgen’s Prolia, allowing its use to treat glucocorticoid-induced osteoporosis (GIOP) in men and women at high risk of fracture.
More: FDA clears Amgen’s Prolia for glucocorticoid osteoporosis
Source: News